Lista de obras - C Lugnier - Dominio Público Uruguay

A new peptide (1150Da) selectively activates the calcium-calmodulin sensitive isoform of cyclic nucleotide phosphodiesterase from human myometrium ⬇️

artículo científico publicado el 30 de abril de 1992

Angiotensin II Potentiates Vasopressin-Dependent cAMP Accumulation in CHO Transfected Cells. Mechanisms of Cross-Talk Between AT1A and V2 Receptors ⬇️

artículo científico publicado el 1 de enero de 1998

Bepridil and flunarizine as calmodulin inhibitors ⬇️

artículo científico publicado el 10 de febrero de 1984

Biflavones of Decussocarpus rospigliosii as phosphodiesterases inhibitors.

artículo científico publicado en 2007

Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells

artículo científico publicado en 1990

Concerted Regulation of cGMP and cAMP Phosphodiesterases in Early Cardiac Hypertrophy Induced by Angiotensin II ⬇️

artículo científico publicado el 3 de diciembre de 2010

Cyclic GMP catabolism up-regulation in MRL/lpr lupus-prone mice is associated with organ remodeling

artículo científico publicado en 2014

Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments ⬇️

artículo científico publicado el 1 de marzo de 2012

Cyclic nucleotide phosphodiesterases (PDE) and peptide motifs

artículo científico publicado en 2010

Delphinidin Inhibits Tumor Growth by Acting on VEGF Signalling in Endothelial Cells

artículo científico publicado en 2015

Design and synthesis of 3-aminophthalazine derivatives and structural analogues as PDE5 inhibitors: anti-allodynic effect against neuropathic pain in a mouse model

artículo científico publicado en 2019

Design, Synthesis, Pharmacological Evaluation and Vascular Effects of Delphinidin Analogues

artículo científico publicado en 2018

Design, synthesis, and pharmacological evaluation of N-acylhydrazones and novel conformationally constrained compounds as selective and potent orally active phosphodiesterase-4 inhibitors

artículo científico publicado en 2012

Disease progression in MRL/lpr lupus-prone mice is reduced by NCS 613, a specific cyclic nucleotide phosphodiesterase type 4 (PDE4) inhibitor

artículo científico publicado en 2012

Down-regulation of cyclic nucleotide phosphodiesterase PDE1A is the key event of p73 and UHRF1 deregulation in thymoquinone-induced acute lymphoblastic leukemia cell apoptosis ⬇️

artículo científico publicado el 31 de agosto de 2010

Effect of the Phosphodiesterase 5 Inhibitor Sildenafil on Ischemia-Reperfusion-Induced Muscle Mitochondrial Dysfunction and Oxidative Stress.

artículo científico publicado en 2019

Endothelium-independent vasorelaxant effect of a Berberis orthobotrys root extract via inhibition of phosphodiesterases in the porcine coronary artery

artículo científico publicado en 2016

Inhibition by papaverine of cGMP and cAMP phosphodiesterases from the rat heart.

artículo científico publicado en 1974

Involvement of cyclic nucleotide-dependent protein kinases in cyclic AMP-mediated vasorelaxation

artículo científico publicado en 1997

La Société de Biologie de Strasbourg : 100 ans au service de la science et de la société

artículo científico publicado en 2020

NCS 613, a PDE4 inhibitor, by increasing cAMP level suppresses systemic inflammation and immune complexes deposition in kidney of MRL/lpr lupus- prone mice